QV Bioelectronics
@qvbio
Followers
247
Following
156
Media
102
Statuses
245
Preclinical medical device startup based in Cheshire, UK. Developing a ground-breaking electric field therapy implant to treat aggressive brain tumours.
Cheshire, UK
Joined September 2019
🚀 Big News from QV Bioelectronics! 🚀 We’re excited to announce breakthrough pre-clinical results for our Glioblastoma therapy! 💼Now Raising Series A More details in our press release below🔗 https://t.co/LBYiNDkz4x
0
0
1
🚨 Big news at QV Bioelectronics! We've been awarded £1.2M by @innovateuk as part of the Biomedical Catalyst to support preparations for a first-in-human trial of GRACE. Full Press Release: https://t.co/SiYX4BkrIj
#BiomedicalCatalyst #InnovateUKFunded
0
0
0
⏳ We’ve got some exciting news to share tomorrow at QV Bioelectronics. Looking forward to sharing more very soon.
0
0
0
Excited to welcome Carl Daintree as QV's new COO! 🚀 Carl brings expertise across medtech, pharma & biotech. At 30 Technology, he led products from prototype to exit, driving clinical studies & market strategy. Thrilled to have him as we advance brain tumour treatment! 🧠
0
0
0
@r_chavarriaga @sameermzuberi @Cheshir77216793 @abbvie @jeanschoenen @BelBrainCouncil @MadalenaPlacido @lisa_toni_burke @EANeurology @vCreateHealth After a rigorous selection process, 5 innovative start-ups are pitching their ground-breaking solutions in the brain health space! 🧠💡 🎤 @qvbio , BrainTale, CREATe Therapeutics, Paperbox and @Rebrain_eu take the stage for this pitch competition in front of five jury members!
0
3
6
@qvbio secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours
🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️ This supports early-stage development & testing, advancing new options and expanding our portfolio.
0
1
0
🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️ This supports early-stage development & testing, advancing new options and expanding our portfolio.
1
0
3
March is Brain Tumor Awareness Month. Our startup is dedicated to innovation in this field, emphasising the critical need for community support and groundbreaking approaches. #BrainTumorAwareness
0
0
2
Our @AlderleyPark campus offers state-of-the-art labs where ideas can flourish. Just look at these pics of @qvbio’s new space!😍 💡Growing their business at #AlderleyPark, QV Bio is a start-up developing surgically implantable #medical devices to treat malignant brain tumours🔬
0
3
2
@InnovateUK & @UKinTX hosted @michelledonelan on her visit to @TXMedCenter to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme. ⚕️ https://t.co/Ux9ZKuT7x4
2
5
15
We will be at the 28th Annual Meeting for the @NeuroOnc this week at the @VanConventions !🍁 Ryan Purdy and Tomisin Olukoga will be presenting our exciting pre-clinical work using Electric Field Therapy (EFT). 💬
0
0
0
Now Presenting: Christopher Bullock of @qvbio (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers. Are you staying informed? https://t.co/DIsqveWHaP
0
1
3
🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (@qvbio) with CEO Christopher Bullock. 🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.
1
2
4
@qvbio and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma https://t.co/svsbO3HP6c
qvbio.co.uk
Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
0
1
0
Our IDH mutant glioma heterogeneity paper with @hoheyn is out in @CellRepMed. A wonderful collective effort by @Enblacar, Ashwin, Inma, and @JuanCNieto1. Special thanks to Matthias and Luigi. Looking forward to expanding on this work! https://t.co/8txzVBOb1T
cell.com
Blanco-Carmona et al. apply single-nucleus RNA-seq and ATAC-seq to profile the cellular heterogeneity in adult IDH-mutant gliomas. They identify a range of transcriptional states within tumor cells...
10
23
113
Excited to be one of the presenting companies at #LSIEurope23
In just six weeks over 150+ of the most exciting emerging companies will take the stage at #LSIEurope23 From seed to growth-stage, pre-revenue to commercial, Europe to the USA, robotics and digital surgery to neuromodulation, LSI Europe '23 will be the epicenter of Medtech.
0
0
1
🌞 Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! 🌱 Michaela, an aspiring biologist, is eager to deepen her understanding of the therapy development process, while also honing her technical skills within a medical devices company. #Welcome
0
0
2
📢 Exciting news as @ukCPI Enterprises invest in @qvbio's GRACE medical device which could increase long-term survival for people with the most common and aggressive type of #braintumours. Fantastic to see two @BW_SciTech customers working together🔄 🤝 https://t.co/kp12usdVEF
0
2
4
Chris Bullock from @qvbio speaking about his career and lessons learned from building a #biomaterials based business
0
2
2
@qvbio Congrats team, QV Bioelectronics has been shortlisted for potential inclusion on our MedTech 50 ranking! Voting is now open:
businesscloud.co.uk
UK companies creating original technology helping to diagnose and treat conditions, mainly in a clinical setting, and other biotechs
0
1
0